Filed Pursuant to Rule 424(b)(5)
Registration Statement No. 333-262384
Registration Statement No. 333-262384-01
Prospectus Supplement to Prospectus dated January 28, 2022
€1,250,000,000
Berkshire Hathaway Finance Corporation
€500,000,000 1.500% Senior Notes due 2030
€750,000,000 2.000% Senior Notes due 2034
Unconditionally and irrevocably guaranteed by
Berkshire Hathaway Inc.
We are offering (i) €500,000,000 of our 1.500% Senior Notes due 2030 and (ii) €750,000,000 of our 2.000% Senior Notes due 2034 (collectively, the “notes”).
Interest on each series of notes will accrue from the date of original issuance, expected to be March 18, 2022 and will be payable annually in arrears on March 18 of each year, commencing on March 18, 2023.
The 1.500% Senior Notes due 2030 will mature on March 18, 2030. The 2.000% Senior Notes due 2034 will mature on March 18, 2034. All of Berkshire Hathaway Finance Corporation’s obligations under the notes will be unconditionally and irrevocably guaranteed by Berkshire Hathaway Inc. (“Berkshire”).
We may redeem either series of notes, in whole or in part, at any time at the redemption prices as described under “Description of the Notes and Guarantees—Optional Redemption.” In addition, we may redeem each series of notes in whole but not in part at any time, if certain events occur involving changes in United States taxation, at the applicable redemption price described under “Description of the Notes and Guarantees—Redemption for Tax Reasons.”
The notes will be senior unsecured indebtedness of Berkshire Hathaway Finance Corporation and will rank equally with all of its other existing and future senior unsecured indebtedness. The guarantees will be senior unsecured obligations of Berkshire and will rank equally with all of its other existing and future senior unsecured obligations. The notes will be issued only in minimum denominations of €100,000 and integral multiples of €1,000 in excess thereof.
We intend to apply to list each series of notes on the New York Stock Exchange (the “NYSE”). The listing applications will be subject to approval by the NYSE. We expect trading in the notes on the NYSE to begin within 30 days after the initial issuance of the notes. If such listings are obtained, we have no obligation to maintain such listings, and we may delist either series of notes at any time.
The risks involved in investing in our debt securities are described in the “Risk Factors” section on page S-7 of this prospectus supplement.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
| | | | | | | | | | | | |
| | Per 1.500% Senior Notes due 2030 | | | Per 2.000% Senior Notes due 2034 | | | Total | |
Initial public offering price (1) | | | 99.701 | % | | | 99.989 | % | | € | 1,248,422,500 | |
Underwriting discount | | | 0.170 | % | | | 0.220 | % | | € | 2,500,000 | |
Proceeds, before expenses, to Berkshire Hathaway Finance Corporation | | | 99.531 | % | | | 99.769 | % | | € | 1,245,922,500 | |
(1) | Plus accrued interest, if any, from March 18, 2022 until the date of delivery. |
The underwriters expect to deliver the notes to purchasers through the book-entry delivery system of Euroclear Bank S.A./N.V. (“Euroclear”) and Clearstream Banking, société anonyme (“Clearstream”), on or about March 18, 2022.
Joint Book-Running Managers
| | |
BofA Securities | | J.P. Morgan |
Prospectus Supplement dated March 8, 2022